CXCR3 and melanoma: On the contrary, enhanced metastasis of CXCR3+ tumor cells to metastatic sites expressing high concentrations of CXCR3 ligands (e.g., brain, lungs, lymph nodes) has been reported as well for melanoma, breast, and colon cancer [91,92,93,94].